Dylan Burger
Senior Scientist, Inflammation & Chronic Disease
Ottawa Hospital Research Institute
Associate Director, Inflammation & Chronic Disease Program
Ottawa Hospital Research Institute
Associate Professor, Department of Cellular and Molecular Medicine
University of Ottawa
Associate Professor, School of Pharmaceutical Sciences
University of Ottawa
Director, Kidney Research Centre
Ottawa Hospital Research Institute
Research Interests
- Extracellular vesicles
- Kidney Disease
- Diabetes
- Hypertension
- Pharmacology
- Vascular Biology
- Biomarkers
- Pregnancy
Brief Biography
Dylan Burger (PhD) is a Senior Scientist at the Ottawa Hospital Research Institute where he serves as Associate Director of the Inflammation and Chronic Disease Program and Director of the Kidney Research Centre. He is an Associate Professor in the Department of Cellular and Molecular Medicine and the School of Pharmaceutical Sciences at the University of Ottawa. He holds a PhD in Physiology and Pharmacology from the University of Western Ontario and is an internationally recognized expert on extracellular vesicles and their role in diabetes, aging, and renal disease.
He has authored more than 120 manuscripts and has received several awards including a KRESCENT New Investigator Award (2014), a Canadian Society of Nephrology New Investigator Lectureship (2016), the University of Ottawa Department of Medicine PhD Scientist Award (2018), an Outstanding Volunteer Award from Hypertension Canada (2022), and the University of Ottawa Educator of the Year –Basic Sciences – Graduate and Postdoctoral Studies (2024)
Dr. Burger is the President-Elect for the Canadian Society of Pharmacology and Therapeutics, and Co-chair of the International Society of Extracellular Vesicles Special Interest Group for the Genitourinary System. He is a founding member of the Lancet Commission on Hypertension and Associate Editor for the European Heart Journal and the Journal of Extracellular Vesicles.
Selected Publications
1. Munkonda MN, Akbari S, Landry C, Turner M, Sun S, Holterman CE, Nasrallah R, Hébert RL, Kennedy CRJ, Burger, D* (2018) “Podocyte-derived Microparticles Promotes Proximal Tubule Fibrotic Signaling Via p38 MAPK and CD36”. J Extracell Ves Feb 2;7(1):1432206.
2. Abolbaghaei A, Langlois MA, Murphy H, Feig D*, Burger D* (2021) “Circulating extracellular vesicles during pregnancy in women with type 1 diabetes”. Biomark Res 9(1):67.
3. Myette RL, Xiao F, Geier P, Feber J, Kennedy CRJ, Burger D (2023) “Urinary Podocyte-derived Large Extracellular Vesicles are Increased in Pediatric Idiopathic Nephrotic Syndrome”. Nephrol Dial Transpl doi: 10.1093/ndt/gfad086
4. Kereliuk SM, Xiao F, Dolinsky VW*, Burger D* (2022) “Extracellular vesicles as an index for endothelial injury and cardiac dysfunction in a rodent model of GDM”. Int J Mol Sci 23(9):4970.
5. Burger D, Thibodeau JF, Holterman CE, Burns KD, Touyz RM, Kennedy CRJ (2014) “Urinary podocyte microparticles identify pre-albuminuric diabetic glomerular injury”. J Am Soc Nephrol 25(7) 1401-1407
6. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Giminez-Roqueplo A, Hering D, López-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG (2016) “A call to action and a life-course strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on Hypertension”. Lancet 26;388(10060):2665-2712.
Diseases, conditions and populations of interest
Research and clinical approaches
